Physician profile
Megha Agarwal
NPI 1508011958
$5,583.25
in general payments reported to CMS, 2019-2025
15 companies · $324 in 2025
The $324 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $485 · 2021: $243 · 2022: $145 · 2023: $353 · 2024: $4,034 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,575 · Food and Beverage: $1,088 · Debt Forgiveness: $32.58 · Travel and Lodging: $16.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,575.00 |
| Food and Beverage | $1,087.79 |
| Debt Forgiveness | $32.58 |
| Travel and Lodging | $16.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $3,822.65 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $276.22 | 2021-2023 | Farxiga |
| Medtronic, INC. | $199.83 | 2021-2025 | Affera Mapping System |
| Abbott Laboratories | $170.02 | 2019-2024 | Pressurewire |
| Biotronik INC. | $156.21 | 2019-2023 | |
| Heartflow, INC. | $141.93 | 2025 | |
| Abiomed | $138.43 | 2023 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.99 | 2019 | |
| Novo Nordisk INC | $118.49 | 2022 | |
| Atricure, INC. | $111.49 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $82.63 | 2019 | |
| Impulse Dynamics (USA) INC. | $81.40 | 2024 | Optimizer |
| Boston Scientific Corporation | $70.99 | 2019 | |
| Janssen Pharmaceuticals, INC | $57.39 | 2021 | |
| Baxter Healthcare | $32.58 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megha Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.